Page 63 - The clinical aspects and management of chronic migraine Judith Anne Pijpers

Support by a headache nurse during withdrawal
References
1 Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol 2004; 3: 475–83.
2 Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 2010; 9: 391–401.
3 Russell MB. Headache: Medication overuse headache--seeking a management consensus. Nat Rev Neurol 2014; 10: 309–10.
4 Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.
5 Silberstein SD, Olesen J, Bousser M-G, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005; 25: 460–5.
6 Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006; 26: 1192–8.
7 Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication- overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 2014; 34: 645–55.
8 Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in
transformed migraine patients with low medical needs. Cephalalgia 2006; 26: 1097–105.
9 Rossi P, Faroni J V., Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in
simple and complicated medication overuse headache. Eur J Neurol 2011; 18: 396–401.
10 Andrasik F, Grazzi L, Usai S, Buse DC, Bussone G. Non-pharmacological approaches to treating
chronic migraine with medication overuse. Neurol Sci 2009; 30: 89–93.
11 Bhola R, Goadsby PJ. A trans-cultural comparison of the organisation of care at headache centres
world-wide. Cephalalgia 2011; 31: 316–30.
12 Diener H-C, Gaul C, Jensen R, Göbel H, Heinze A, Silberstein S. Integrated headache care. Cephalalgia
2011; 31: 1039–47.
13 Gaul C, Van Doorn C, Webering N, et al. Clinical outcome of a headache-specific multidisciplinary
treatment program and adherence to treatment recommendations in a tertiary headache center:
An observational study. J Headache Pain 2011; 12: 475–83.
14 Jensen R, Zeeberg P, Dehlendorff C, Olesen J. Predictors of outcome of the treatment programme
in a multidisciplinary headache centre. Cephalalgia 2010; 30: 1214–24.
15 The international Classification of Headache disorder: 2nd edition. Cephalagia 2004; 24: 9–160.
16 Hagen K, Jensen R, Bøe MG, Stovner LJ. Medication overuse headache: A critical review of end
points in recent follow-up studies. J Headache Pain 2010; 11: 373–7.
17 Wieser T, Walliser U, Womastek I, Kress HG. Dysfunctional coping in headache: Avoidance and
endurance is not associated with chronic forms of headache. Eur J Pain 2012; 16: 268–77.
18 Dindo L, Recober A, Marchman J, O’Hara M, Turvey C. Depression and Disability in Migraine: The
Role of Pain Acceptance and Values-Based Action. Int J Behav Med 2014; : 1–9.
19 Natalie J Wiendels, Philip Spinhoven, Arie Knuistingh Neven, Frits R Rosendaal, Frans G Zitman, Willem J J Assendelft and MDF. The role of catastrophizing and locus of control in chronic frequent
headache. 2008.
20 Mérelle SYM, Sorbi MJ, Van Doornen LJP, Passchier J. Migraine patients as trainers of their
fellow patients in non-pharmacological preventive attack management: Short-term effects of a
randomized controlled trial. Cephalalgia 2008; 28: 127–38.
21 Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces
headache days in chronic migraine: A randomized, double-blind, placebo-controlled study.
Cephalalgia 2007; 27: 814–23.
22 Silberstein S, Lipton R, Dodick D, et al. Topiramate Treatment of Chronic Migraine: A Randomized,
Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures. Headache 2009; 49: 1153–
62.
23 Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for Treatment of Chronic Migraine:
Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT
Clinical Program. Headache J Head Face Pain 2010; 50: 921–36.
24 Diener H-C. Detoxification for medication overuse headache is not necessary. Cephalalgia 2012; 32: 423–7.
3
61